Bret Barnhizer, NanoLogix CEO remarked, "The efforts of the last 16 months to build a solid business and biotechnology foundation are bearing fruit. With the CL Solutions joint development project, first BNC/BNP kit sales to a highly respected major institution involved in U.S. defense efforts against bioterrorism, and the associated potential for sales to a broad range of customers, we have achieved the goals set forth last year in our business plan. Directors John Chatterton and Dr. Robert Ollar have clearly demonstrated their faith in the future of the company by accepting 160,000 shares annually, contrasted with the 1,000,000 shares drawn by directors in the past. We are now on track for establishing a sustaining revenue stream that will enable expansion of production for BNC/BNP technologies and also increase our research and development efforts for hydrogen extraction from waste, with a focus on turning that waste into a reliable source of alternative energy as well as reducing the volume of waste now flowing into our ecosystem."
About CL Solutions, LLC.
A leader in the field of bioremediation, CL Solutions rapidly and affordably bioremediates soil and groundwater contaminated with hydrocarbons and chlorinated solvents. The company's products, CL-Out(TM) and Petrox(TM), have been field-proven to work faster, work better, and cost less than other hazardous waste cleanup solutions.
About NanoLogix, Inc.
NanoLogix is an industry innovator in the research, development, and commercialization of biotechnologies, applications and processes. The Company has multiple Patents and Patents Pending for rapid medical testing, bioremediation, and Hydrogen Production utilizing bioreactor technology. Information on NanoLogix is available at http://www.nanologixinc.com .
This press release contains statements which may constitut
|SOURCE NanoLogix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved